Similar articles

• Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.

  Giblett ER. Giblett ER. Ciba Found Symp. 1978;(68):3-18. doi: 10.1002/9780470720516.ch2. Ciba Found Symp. 1978. PMID: 115664 Review. No abstract available.
• Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.

  Seegmiller JE. Seegmiller JE. Monogr Hum Genet. 1978;10:88-91. doi: 10.1159/000401572. Monogr Hum Genet. 1978. PMID: 102926 No abstract available.
• Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.

  Carson DA, Kaye J. Carson DA, et al. Ciba Found Symp. 1978;(68):115-33. doi: 10.1002/9780470720516.ch8. Ciba Found Symp. 1978. PMID: 115660 Review.
• Enzyme defects and immune dysfunction.

  Rosen FS. Rosen FS. Nature. 1978 Dec 7;276(5688):559-60. doi: 10.1038/276559a0. Nature. 1978. PMID: 102999 No abstract available.
• Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.

  Simmonds HA, Sahota A, Potter CF, Cameron JS. Simmonds HA, et al. Clin Sci Mol Med. 1978 May;54(5):579-84. doi: 10.1042/cs0540579. Clin Sci Mol Med. 1978. PMID: 108044 No abstract available.